drugset / Trial / NCT01515397

Comparison of Two Gelatine Solutions

NCT01515397

Phase 3 Completed 40 enrolled B. Braun Melsungen AG
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of volume replacement is to compensate a reduction in the intravascular volume e.g. during surgery and to counteract hypovolemia in order to maintain hemodynamics and vital functions. To achieve this, different plasma substitutes are available: Albumin, dextran, hydroxyethylstarches and gelatine. The aim of this study is to demonstrate that acid-base alterations during elective abdominal surgery can be reduced by the use of a new gelatine solution.

Timeline

Start
2011-12
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gelofusine 4% Unknown Intravenous
Subject Gelofusine balanced Unknown Intravenous
Subject NaCl Unknown Intravenous
Subject Sterofundin ISO Other / unclassified Intravenous

Indications

No indication recorded.